首页 | 本学科首页   官方微博 | 高级检索  
检索        


MicroRNA-210 overexpression predicts poorer prognosis in glioma patients
Institution:1. Department of Neurosurgery, Wuxi Second People’s Hospital Affiliated to Nanjing Medical University, 68 Zhongshan Road, Wuxi City 214002, People’s Republic of China;2. Department of Neurosurgery, First Affiliated Hospital of Nanjing Medical University, Nanjing City, People’s Republic of China;3. Department of Neurosurgery, Nanjing Brain Hospital Affiliated to Nanjing Medical University, Nanjing City, People’s Republic of China;1. Bernard and Irene Schwartz Interventional Neuroradiology Section, Department of Radiology, NYU Langone Medical Center, New York University School of Medicine, 660 First Avenue, 7th Floor, New York, NY 10016, USA;2. Department of Neurosurgery, NYU Langone Medical Center, New York University School of Medicine, New York, NY, USA;3. Department of Neurology, NYU Langone Medical Center, New York University School of Medicine, New York, NY, USA;1. Department of Neurology, Auckland District Health Board, Auckland City Hospital, Park Road, Grafton, Auckland, New Zealand;2. Department of Orthopaedics, Auckland District Health Board, Auckland, New Zealand;1. Department of Neurosurgery, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52245, USA;2. Department of Otolaryngology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA;1. Wake Forest School of Medicine, Department of Neurology, 1 Medical Center Boulevard, Box 2669, Winston Salem, NC 27157, USA;2. Wake Forest School of Medicine, Department of Neurosurgery, Winston Salem, NC, USA;3. Wake Forest School of Medicine, Department of Pathology, Winston Salem, NC, USA
Abstract:
Keywords:Glioma  MicroRNA-210  Overall survival  Progression-free survival
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号